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Aim: To compare the anesthetic effectiveness of epidural levobupivacaine and bupivacaine without adjuvant medication in patients who
were to have elective operations on the lower extremities and hips.
Materials and methods: This study was conducted on a total of 70 ASA I-II patients aged between 30 and 70 years, who underwent
elective hip and lower extremity operations. The patients that received bupivacaine were assigned to Group B (n = 35) and those that
received levobupivacaine to Group L (n = 35).
Results: No statistically significant difference was found between the groups in terms of the onset and regression times of the sensory
and motor blockade, time to reach dermatomes, initial analgesic requirement time, resolution time of the motor block,
patient and surgeon satisfaction, heart rate, noninvasive systolic artery pressure, diastolic artery pressure, mean artery pressure, and
peripheral oxygen saturation values (P > 0.05).
Conclusion: Levobupivacaine could be a good alternative to bupivacaine in patients administered epidural anesthesia in elective hip and
lower extremity operations in terms of hemodynamic parameters, quality of anesthesia and analgesia, patient and surgeon satisfaction,
and complications.
Key words: Epidural anesthesia, bupivacaine, levobupivacaine, lower extremity and hip operation

1. Introduction
Spinal and epidural anesthesia techniques are regional
anesthesia methods that are widely used, especially in
lower abdominal and lower extremity operations (1,2).
Epidural anesthesia is a versatile technique widely used in
anesthetic practice. Its potential to decrease postoperative
morbidity and mortality has been demonstrated by
numerous studies (3).
Stereoisomers of the agents are being developed for
use instead of the isomers, in order to avoid the toxic
effects of local anesthetic agents as much as possible. S
forms of the isomers are less toxic and provide longerlasting analgesia (4,5). We aimed to compare anesthetic
effectiveness of epidural levobupivacaine and bupivacaine
without adjuvant medication in patients who had elective
lower extremity and hip operations.
2. Materials and methods
This study was designed and conducted with the approval
of the faculty’s ethics committee and written consents
* Correspondence: mine.celik74@gmail.com
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were obtained from patients in the Atatürk University
Faculty of Medicine, with a total of 70 American Society
of Anesthesiology classification (ASA) I-II patients, aged
between 30 and 70 years, who underwent elective hip
and lower extremity operations enrolled in a prospective,
randomized double-blind study.
The patients were assigned randomly by a computer
randomization program to receive either isobaric
bupivacaine (Marcaine 0.5%, Astra Zeneca, UK) as
Group B (n = 35) or to receive isobaric levobupivacaine
(Chirocaine 0.5%, Abbott, Norway) as Group L (n = 35).
The patients that accepted the regional anesthesia
and did not have any contraindication for this, with a
height of between 150 and 180 cm, were included in the
study. Patients who rejected the regional anesthesia, were
substance abusers or alcohol addicts, or had an allergy
to any drugs in the study protocol were excluded from
the study. All the patients were premedicated before the
operation with 2 mg of midazolam (Dormicum, Roche,
France).
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The patients were hydrated with 10 mL/kg of Ringer’s
lactate before the epidural analgesia. Electrocardiography
with standard DII-derivation and monitoring (CAMS II
Comprehensive Anesthesia Monitor) of basal systolic,
diastolic, and mean blood pressures, and heart rate (HR)
was performed, and peripheral oxygen saturation (SpO2)
was measured with pulse oximetry for all patients taken to
the operating room. Demographic data, HRs, and systolic,
diastolic, and mean blood pressure values were recorded
for all patients before the blockade.
In all patients, the region in which the epidural catheter
(Braun, Melsungen, Germany) was inserted was widely
cleaned with an antiseptic solution (10% povidone-iodine)
and covered with a sterile drape. An epidural catheter was
inserted from the L3-L4 or L4-L5 space, with the patient
in the sitting position, using the hanging drop technique
with an 18-gauge Tuohy needle. The catheter was left at 4
cm in the epidural space and fixed to be protected. After
aspiration of the blood, and when blood and oxidative
stress was defined as negative, Group B received 5 mL
of 0.5% isobaric bupivacaine in the epidural space with
2-min intervals to a total of 15 mL, and Group L received 5
mL of 0.5% isobaric levobupivacaine with 2-min intervals
to a total of 15 mL.
Systolic arterial pressure (SAP), diastolic arterial
pressure (DAP), mean arterial pressure (MAP), HR, and
SpO2 were measured and recorded after patients were
taken to the operating table, following injection of the
epidural solution (T1), at 5 (T2), 10 (T3), 20 (T4), 30 (T5)
and 60 (T6) min after the solution was administered, and
postoperatively in the first (T7) and second (T8) hours.
The sensory block was tested at 2-min intervals by
pinprick into the region corresponding to each dermatome
of both anterior axillary lines. Absence of pain from a
pinprick at the T10 (umbilicus) level was recorded as the
onset time of sensory block. The last dermatome in which
the patient did not feel pain was accepted as the maximal
level of sensory block. Times of onset, reaching of T6
(xiphoid level), regression of 2 segments, and termination
were recorded during this monitoring.
The duration between the epidural injection and when
sensory block regressed to the L1 (inguinal region) level
was accepted as the epidural analgesia duration. When
the sensory block reached the thoracal (T6) level, it was
accepted as sufficient to start the operation. The degree of
motor block of the lower extremity was evaluated using
the modified Bromage scale every 2 min.
The Bromage score and onset, termination, and
recovery times of the motor block were recorded. Recovery
time of motor block was considered as the time when the
maximal Bromage score dropped to 1 point.
Postoperative pain of the patients was evaluated
with visual analog scale (VAS) scores. The patients were

asked to mark a position indicating the pain severity on a
continuous horizontal line between 0 (no pain) at one end
and 10 (the most severe pain) at the other end, measured
in centimeters.
When VAS scores of the patients were 4 or higher, 3
mg of morphine diluted with 50 µg of fentanyl and 11 mL
of isotonic solution was administered as a total of 15 mL
of epidural fluid from the epidural space for postoperative
analgesia. In addition, initial analgesia requirement time,
side effects such as nausea and vomiting or hypotension
and bradycardia, patient–surgeon satisfaction, and
analgesia quality were recorded for all the patients. Inıtial
analgesia requirement time was accepted as the time when
the patients had a postoperative VAS score of 4 or higher.
The patients were stabilized with 1 mg of atropine
(Galen, İstanbul, Turkey) when their HRs dropped under
50 beats/min and with ephedrine in 10-mg doses when
their MAPs decreased by a rate of 30% of the preoperative
value (OSEL, İstanbul, Turkey).
Analgesia quality was evaluated in 3 stages as excellent
(no pain, patient comfortable), good with sedation
(required mild analgesia), and poor (discomfort with
moderate pain or required general anesthesia).
We planned to use propofol if agitation and discomfort
were observed in patients. If required, a 30-mg I.V. bolus or
1–2 mg kg–1 h–1 propofol infusion (propofol 1%, Fresenius,
Germany) was administered.
Surgical satisfaction was recorded as good or poor
by asking the surgeons 15 min after the beginning of
operation.
The patients taken to the recovery room at the end
of the operation were monitored for 60 min. Following
stable hemodynamic findings (basal systolic and diastolic
blood pressures, HRs), the patients were sent to the clinical
wards.
The patients were questioned by another anesthetist
about head and back pain and motor and neurological
deficit the day after surgery. In addition, the termination
time of motor block was asked (when they were able to
move their feet) and recorded.
Data were expressed as number, percentage, mean, and
standard deviation. Analysis of the data was performed
with SPSS 18.0. The Mann–Whitney U test was used in
analysis of the continuous variables and the chi-square
test for the analysis of categorical variables. P < 0.05 was
considered statistically significant.
3. Results
Mean demographic features of the patients such as age,
weight, and height were 55.91 vs. 56.77 years, 75.87 vs.
76.22 kg, and 1.76 vs. 1.77 m, respectively, in group L and
Group B, and no significant difference was found between
the groups.
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No significant difference was found in terms of onset
and regression times of sensory block, onset and regression
times of motor block, time for sensory block to reach T6,
initial analgesic requirement time, and operation duration
(Table 1).
When values of the groups were compared, sensory
block was seen to reach T6 earlier, to terminate later,
and to last longer in Group B. However, this was not
statistically significant (P > 0.05). Maximum motor levels
of the patients in Group B and Group L were compared
according to the case number. There was no significant
difference between the groups (Table 2).
When mean SAP values of the groups were compared,
no significant difference was seen between Group B and
Group L in SAP values at 5, 10, 20, 30, or 60 min of the
epidural block; at the end of the operation; or at the first
and second hours after the operation, as compared to the
preoperative SAP values (Table 3).
When DAP and MAP values of the groups were
compared, no significant difference was seen between
Group B and Group L in DAP values at 5, 10, 20, 30, and 60
min of the epidural block; at the end of the operation; or at
the first and second hours after the operation, as compared
to the preoperative DAP values (P > 0.05).
When pulse values of the groups were compared, no
significant difference was found between Group B and
Group L in HR values at 5, 10, 20, or 30 min of the epidural
block; at the end of the operation; or at the first and
second hours of postoperative time, as compared to the
preoperative HR values. However, a borderline difference
was found at 60 min of epidural block between groups (P
= 0.049) (Table 4).

When SpO2 values of the groups were compared, no
significant difference was found between Group B and
Group L in SpO2 values at 5, 10, 20, or 30 min of epidural
block; at the end of the operation; or at the first and second
hours after the operation, as compared to the preoperative
SpO2 values.
When side effect rates of the groups were compared,
hypotension and nausea-vomiting were seen at a higher
rate in Group B, while Group L had fewer side effects. In
Group B hypotension was found in 5 patients, bradycardia
in 3 patients, nausea-vomiting in 3 patients, and tremors in
2 patients. In Group L hypotension was found in 4 patients,
bradycardia in 1 patient, nausea-vomiting in 1 patient, and
tremors in 1 patient. Postoperative side effects were found
to be similar in both groups. No significant side effect was
seen in any of the patients after the operation (Table 5).
In our study, analgesia quality was found as excellent in
31 patients and good with sedation in 4 patients in Group
B, while it was found as excellent in 32 patients and good
with sedation in 3 patients in Group L (Table 6).
Patient and surgeon satisfaction, analgesia quality,
and VAS values were compared in all the patients, and no
significant difference was found between the groups.
4. Discussion
Advantages of regional anesthesia include consciousness
of the patient, early awareness of complications owing
to the ongoing cooperation with the patient, protection
of the airway reflexes, less thromboembolism, a
better hemodynamic stability compared to general
anesthesia, and no or fewer motor blocks, while it has

Table 1. Comparison of sensory-motor blockade onset and regression times, initial analgesic requirement time, and operation durations
of the patients.

Sensory block
onset time (min)
Time of sensory block
to reach T6 (min)
Motor block
onset time (min)
Sensory block
regression time (min)
Motor block
regression time (min)
Initial analgesic
requirement time (min)
Operation duration(min)
Time of motor block to reach
maximum level (min)
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Group L

Group B

T

P

6.86 ± 1.94

6.80 ± 1.812

–0.143

0.886

24.54 ± 2.27

23.97 ± 1.485

–1.221

0.222

15.37 ± 1.46

15.60 ± 1.288

–0.727

0.467

180.54 ± 9.34

183.17 ± 7.48

–1.291

0.197

191.60 ± 9.51

195.60 ± 6.40

–1.801

0.72

207.86 ± 45.96

223.29 ± 40.76

–1.358

0.175

140.29 ± 22.94

140.57 ± 23.51

–0.172

0.863

26.80 ± 1.96

26.54 ± 1.88

–0.548

0.574
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Table 2. Bromage scale of the patients in Group B and Group L.
Bromage scale

Group L

Group B

P-values

0
1

13

45%

16

55%

0.550

2

22

53%

19

47%

0.430

3

the disadvantages of late onset of its effects and possible
development of motor block (6). This method is preferred
by anesthesia physicians, especially in patients who suffer
from respiratory system problems (7). Epidural anesthesia
followed by epidural postoperative analgesia is also
preferred for high-risk cardiac patients (8).
Bupivacaine is a long-acting local anesthetic from the
amino-amide subgroup, which is frequently used in local
infiltration and epidural and spinal anesthesia. Although it
has been safely used in all types of regional applications for
many years, fatal cardiotoxic effects may be seen following
accidental intravascular injection (9,10). An important
cause of cardiovascular side effects is bupivacaine leaving
sodium channels slowly. Therefore, local anesthetics with
similar actions to bupivacaine, but with fewer effects on
the cardiovascular system, have been needed.
Levobupivacaine is an S (-) enantiomer of racemic
bupivacaine. The affinity of the S (-) isomer to the cardiac
sodium channel in the inactive state is lower than that
of the R (+) isomer (11–13). In the studies conducted,
levobupivacaine has been demonstrated to present similar
pharmacokinetic characteristics to bupivacaine and to
be less cardiotoxic and neurotoxic. Levobupivacaine is
considered a good alternative to bupivacaine, because of
its lower side effects on the cardiovascular and central
nervous system (14–17).
In their study of 88 patients, Cox et al. (18) found
that 0.5% and 0.75% levobupivacaine, administered for

epidural anesthesia, was tolerated by patients as well as
bupivacaine was, and there was not a significant difference
in producing sensory block, maximal diffusion, and onset
time of motor block. They defined the time of sensory
block as about 460 min for 0.75% levobupivacaine and
about 377 min for 0.55% bupivacaine. They reported
that the time of sensory block was 32 or 45 min longer
compared to equal doses of bupivacaine (about 345 min)
and motor block did not occur in 14 of 29 patients who
received levobupivacaine, whereas this was the case in
only 9 of 29 patients who received bupivacaine.
Kopacz and Allen (19) reported that sensory block
onset time may be between 5 and 15 min after the 0.5%
levobupivacaine injection is completed, and this was
similar to the onset time of the effect of 0.5% bupivacaine.
In our study, 75 mg of 0.5% isobaric bupivacaine
and 0.5% isobaric levobupivacaine of similar doses were
compared in 2 groups, including 35 patients in each that
underwent elective hip and lower extremity surgery, in
terms of anesthetic and hemodynamic parameters. No
toxicity signs were found in any patient. We attributed
this to the fact that patients were selected from low-risk
groups, and the doses were not at high limits.
In our study, no difference was found between the
times to reach the sensory block sufficient for the surgical
intervention (23.97 min in Group B and 24.54 min in
Group L). Motor block onset time was found as 15.60
min in Group B and 15.37 min in Group L, while the
times for the sensory block to regress to 2 segments were
found as 183.17 and 180.54 min in Group B and Group
L, respectively. Regression time of the motor block in the
lower extremities was found as 195.60 min in Group B
and 191.60 min in Group L. According to these results, no
statistically significant difference was found between the
groups in terms of the sensory block onset and regression
times, motor block onset and regression times, time of
sensory block to reach T6, initial analgesic requirement
time, and mean operation durations.

Table 3. SAP values of the groups.
Group L
(mean ± SD)

Group B
(mean ± SD)

T

P

Basal (T1)

125.20 ± 11.15

123.86 ± 11.64

–0.722

0.470

5 min (T2)

123.14 ± 10.67

122.31 ± 10.15

–0.365

0.715

10 min (T3)

122.34 ± 11.01

123.63 ± 10.61

–0.768

0.442

20 min (T4)

122.09 ± 10.07

122.40 ± 10.11

–0.238

0.812

30 min (T5)

119.14 ± 8.34

117.49 ± 9.78

–0.628

0.430

60 min (T6)

119.60 ± 7.94

118.69 ± 7.92

–0.580

0.562

Postop. first hour (T7)

121.54 ± 9.86

121.18 ± 8.10

–0.329

0.742

Postop. second hour (T8)

124.43 ± 8.20

127.29 ± 7.89

–1.546

0.122

SAP (mmHg)
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Table 4. HR values of the groups. *: P < 0.05.
HR (beats/min)
Basal (T1)

Group L
(mean ± SD)

Group B
(mean ± SD)

T

P

89.20 ± 10.363

89.49 ± 6.793

–0.497

0.619

5 min (T2)

87.66 ± 7.174

89.51 ± 7.056

–0.809

0.419

10 min (T3)

87.77 ± 11.149

89.71 ± 10.366

–1.023

0.306

20 min (T4)

87.57 ± 8.012

87.34 ± 7.227

–0.077

0.939

30 min (T5)

86.11 ± 8.953

87.83 ± 7.342

–0.619

0.536

60 min (T6)

84.20 ± 8.781

88.06 ± 6.553

–1.970

0.049*

Postop. first h (T7)

84.83 ± 8.266

87.83 ± 7.286

–1.943

0.052

Postop. second h (T8)

86.17 ± 7.015

88.31 ± 6.101

–1.677

0.093

Kopacz and Allen (19) found in the patients to
which they administered epidural bupivacaine and
levobupivacaine that motor block time was about 1 min
shorter in the group that received levobupivacaine. They
reported that extremity block occurred within 30 min in
only 14% of the patients that received levobupivacaine,
compared to 71% of the patients that received bupivacaine.
In our study, when the degrees of motor block over time
were compared, no difference was found between the
groups (P > 0.05). In Group B and Group L, the degree
of motor block reached its peak level within 30 min,
remained at the same level at 60 min, and then decreased
over time, completely resolving in 350 min.
Our study indicates that epidurally administered
bupivacaine produced an analgesia duration of 363 min
and levobupivacaine a duration of 347 min, which means
that both medications caused a similar analgesic effect.
Maximum sensory block height was at the T4 level and
maximum motor block diffusion occurred 30 min after the
administration, and complete motor block was not seen in
any patients.
In their studies, Cox et al. (18), Bader et al. (20), and
Kopacz and Allen (19) evaluated SAP, DAP, MAP, HR, and
SpO2 parameters and did not find a significant difference
between the 2 groups. Similarly, we compared the same
parameters in our study. No statistically significant
difference was found in these parameters after epidural
block compared to the baseline values.
In their study with patients undergoing caesarean
section, Bader et al. (20) epidurally administered 30 mL
of 0.5% levobupivacaine in the first group and 30 mL of
0.5% bupivacaine in the second group, and they found that
incidence of hypotension was lower in the levobupivacaine
group. We also obtained the same result in this study.
When Kopacz and Allen (19) compared
levobupivacaine and bupivacaine in terms of side effects,
they found a similar tolerability profile and, in their study
in which levobupivacaine was epidurally administered,
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they reported that cardiac depression or central nervous
system (CNS) toxicity were not encountered following
vascular absorption or direct intravascular injection,
with the exception of minimal CNS symptoms (transient
agitation and disorientation), which was seen in one
patient who incidentally received intravascular injection,
and they did not find any signs of cardiovascular system
toxicity. In our study, no significant difference was found
between the groups in terms of the side effects that were
encountered in the perioperative period.
In animal studies, CNS symptoms and convulsions
have been shown to occur at lower doses of bupivacaine
than levobupivacaine. In a double-blind, randomized
study by Van et al. (16) with 12 voluntary patients, 40 mg
of intravenously administered levobupivacaine was found,
on electroencephalogram, to produce less CNS depression
compared to 40 mg of bupivacaine.
Bhatt et al. (21) reported that side effects of
levobupivacaine with bupivacaine and other local
anesthetics of the amide groups were the same. The most
common reported side effects are nausea, postoperative
pain, hypotension, fever, headache, and vomiting. These
drugs all had a similar safety profile and a low incidence
of adverse effects. There was no statistically significant
difference in side effects. In our study, as well, there was
no statistically significant difference in term of side effects.
Table 5. Comparison of the side effects seen in the groups during
the operation.
Side effect

Group L

Group B

P

Hypotension

4

5

0.50

Bradycardia

1

3

0.30

Nausea-vomiting

1

3

0.30

Tremor

1

2

0.50

Coughing

0

0

–
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Table 6. Comparison of the analgesia quality in the groups.
Group L
Analgesia
quality

Excellent
Good with sedation

No significant difference of the quality of analgesia
was recorded between these local agents and all of them
provided efficient clinical anesthesia (18,22). In our study,
no statistically significant difference was found in the
quality of analgesia.
After epidural blockade there was a statistically
significant difference in terms of HRs at 60 min. However,
this difference of HR is not significant clinically.

32
3

Group B
31
4

P-value
1.00

Finally, we concluded from this study that there
was no difference between 0.5% bupivacaine and 0.5%
levobupivacaine in patients receiving epidural anesthesia
for hip and lower extremity operations, in terms of motor
and sensory blockade onset and regression times, time
of sensory block to reach T6, VAS scores, hemodynamic
parameters, patient and surgeon satisfaction, side effects,
and postoperative analgesia requirement times and that
levobupivacaine may be a good alternative to bupivacaine.
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